Clinical features and outcome of dermal squamous cell carcinoma in 193 dogs (1987‐2017). (13th March 2019)

• Record Type: Journal Article
• Authors: Willcox, Jennifer L.; Marks, Stanley L.; Ueda, Yu; Skorupski, Katherine A.
• Is Part Of: Veterinary and comparative oncology. Volume 17:Number 2(2019:Jun.)
• Page Start: 130
• Page End: 138
• Publication Date: 2019-03-13
• Subjects: actinic -- cancer -- canine -- skin -- solar; Veterinary oncology -- Periodicals; Neoplasms -- veterinary -- Periodicals; 636.0896994005
• DOI: 10.1111/vco.12461
• Languages: English
• ISSNs: 1476-5810

Abstract

Abstract : Squamous cell carcinoma (SCC) is a frequently recognized dermal tumour in dogs and has been described as a common pathology induced by solar ultraviolet radiation exposure. Little has been published about this neoplasm with regard to clinical features and outcome in dogs. This retrospective study included 193 dogs from a single institution histopathologically diagnosed with SCC of the dermis. Thirty‐eight percent of all dogs had documented histopathologic actinic change. The overall median survival time was 1004 days, with the population demonstrating actinic change associated with a significantly longer survival time (median 1359 days, range 16‐3530 days) compared to dogs without actinic change (median 680 days, range 16‐3066 days) and this achieved significance on multivariate analysis (hazard ratio 0.42, 95% confidence interval 0.193‐0.930, P = 0.032). These data demonstrate increased survival of dogs with SCC demonstrating actinic change over those with non‐actinic SCCs, and purports long‐term survival for these animals. Dogs received a variety of treatment approaches as a retrospective study, and future prospective studies will be necessary to investigate whether adjunct therapies such as radiation or chemotherapy offer improvement in survival for dermal SCC in the dog.